HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months

Diabetes

Volumn 55, Issue 6, 2006, Pages 1895-1898

  Edghill, Emma L ^a   Dix, Rachel J ^b   Flanagan, Sarah E ^a   Bingley, Polly J ^b   Hattersley, Andrew T ^a   Ellard, Sian ^a   Gillespie, Kathleen M ^b,c  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Permanent neonatal diabetes; PNDM

Indexed keywords

ARTICLE; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; KCNJ11 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 33748333167     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0094     Document Type: Article

References (22)

1. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT: Genetic aetiology of hyperglycaemia determines response to treatment in diabetes. Lancet 362:1275-1281, 2003
2. Devendra D, Eisenbarth GS: 17. Immunologic endocrine disorders. J Allergy Clin Immunol 111 (Suppl. 2):S624-S636, 2003
3. Shield JP: Neonatal diabetes: new insights into aetiology and implications. Horm Res 53 (Suppl. 1):7-11, 2000
4. Hattersley AT, Ashcroft FM: Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 54:2503-2513, 2005
5. Gloyn AL, Cummings EA, Edghill EL, Harries LW, Scott R, Costa T, Temple IK, Hattersley AT, Ellard S: Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel. J Clin Endocrinol Metab 89:3932-3935, 2004
6. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849, 2004
7. + channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years. Diabetes 53:2998-3001, 2004
8. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H, Abuelo D, Phornphutkul C, Molnes J, Bell GI, Gloyn AL, Hattersley AT, Molven A, Sovik O, Njolstad PR: Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713-2718, 2004
9. Vaxillaire M, Populaire C, Busiah K, Cave H, Gloyn AL, Hattersley AT, Czernichow P, Froguel P, Polak M: Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes 53:2719-2722, 2004
10. Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo G, Crino A, Lorini R, Cerutti F, Vanelli M, Barbetti F: KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 25:22-27, 2005
11. Flanagan SE, Edghill E, Gloyn AL, Stals K, Ellard S, Hattersley AT: Kir6.2 gene mutations are a common cause of diabetes before 6 months and the presence of neurological features varies with the site of the mutataion. Diabet Med 22: 10, 2005
12. Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, Malecki MT: The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation. Diabetologia 48:1029-1031, 2005
13. Zung A, Glaser B, Nimri R, Zadik Z: Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 89:5504-5507, 2004
14. Codner E, Flanagan S, Ellard S, Garcia H, Hattersley AT: High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation. Diabetes Care 28:758-759, 2005
15. Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, Mazzella M, Cherubini V, Barbetti F, Martinetti M, Cerutti F, Prisco F: Permanent diabetes mellitus in the first year of life. Diabetologia 45:798-804, 2002
16. Botha JL, Parker H, Raymond NT, Swift PG: Diabetes diagnosed before the age of 2 years: mortality in a British cohort 8-17 years after onset. Int J Epidemiol 21:1132-1137, 1992
17. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA: Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710, 1997
18. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA, Todd JA, Gough SC: Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 76:157-163, 2005
19. Hattersley AT, Tooke JE: The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 353:1789-1792 1999
20. Njolstad P, Sovik O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F, Undlien D, Shiota C, Magnuson M, Molven A, Matschinsky F, Bell G: Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588-1592, 2001
21. Larsson HE, Lynch K, Lernmark B, Nilsson A, Hansson G, Almgren P, Lernmark A, Ivarsson SA: Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 48:1484-1491, 2005
22. Ronningen KS, Keiding N, Green A: Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 44 (Suppl. 3):B51-B59, 2001